Society for Immunotherapy of Cancer

Organization

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1186/1479-5876-10-205 Cancer classification using the Immunoscore: a worldwide task force
https://doi.org/10.1186/1479-5876-10-1 The immune score as a new possible approach for the classification of cancer
https://doi.org/10.1186/1479-5876-9-214 Defining the critical hurdles in cancer immunotherapy
https://doi.org/10.1186/s40425-019-0594-0 The promise of Immuno-oncology: implications for defining the value of cancer treatment
https://doi.org/10.1182/blood-2016-08-732636 NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease
https://doi.org/10.1158/0008-5472.can-21-0483 Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
https://doi.org/10.1016/j.jtct.2025.05.014 Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTR
https://doi.org/10.1172/jci143950 The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease
https://doi.org/10.1186/s12967-017-1352-z Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts
https://doi.org/10.1016/j.jmoldx.2024.05.002 Recommendations for Tumor Mutational Burden Assay Validation and Reporting
https://doi.org/10.1080/2162402x.2021.2015170 Mice transgenic for human CTLA4-CD28 fusion gene show proliferation and transformation of ATLL-like and AITL-like T cells
https://doi.org/10.1172/jci193745 CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models
https://doi.org/10.1158/1078-0432.ccr-05-0250 Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia
https://doi.org/10.1007/978-3-319-55947-6_12 Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer
https://doi.org/10.4161/onci.19268 The immuno-oncology framework
https://doi.org/10.1007/s00262-012-1226-4 Extended survival observed in adoptive activated T lymphocyte immunotherapy for advanced lung cancer: results of a multicenter historical cohort study
https://doi.org/10.1186/1479-5876-9-155 SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery
https://doi.org/10.1038/bmt.2012.57 Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis
https://doi.org/10.1016/j.jtct.2022.11.028 Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas
https://doi.org/10.1002/cam4.6844 Pan‐cancer analysis of TIM‐3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity
https://doi.org/10.1186/s12916-024-03293-3 Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer
https://doi.org/10.1016/j.jtho.2024.09.1242 EP.12H.01 A Phase 2 Study to Assess BDTX-1535, An Oral EGFR Inhibitor, in Patients with Non-Small Cell Lung Cancer
https://doi.org/10.1007/s00262-025-04197-8 CD40 transcriptomic expression patterns across malignancies: implications for clinical trials of CD40 agonists
https://doi.org/10.1097/cji.0b013e31821dcb50 Endothelial Nitric Oxide Synthase Is a Key Mediator of Interleukin-2-Induced Hypotension and Vascular Leak Syndrome
https://doi.org/10.1186/1479-5876-8-130 Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
https://doi.org/10.4049/jimmunol.181.9.6525 Human Plasmacytoid Dendritic Cells Interact with gp96 via CD91 and Regulate Inflammatory Responses
https://doi.org/10.4049/jimmunol.1003946 Split Immunity: Immune Inhibition of Rat Gliomas by Subcutaneous Exposure to Unmodified Live Tumor Cells
https://doi.org/10.1002/art.39751 Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
https://doi.org/10.1186/1479-5876-9-18 The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program
https://doi.org/10.1111/j.1524-4725.2010.01848.x Allograft and Overall Survival of Patients with Posttransplant Skin Cancer
https://doi.org/10.1186/2051-1426-1-1 Introducing the society for immunotherapy of cancer’s new journal: journal for immunoTherapy of cancer
https://doi.org/10.1186/2051-1426-2-s3-p228 STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment
https://doi.org/10.4103/wjtcm.wjtcm_12_20 Advantages of anti-inflammatory acupuncture in treating sepsis of coronavirus disease 2019
https://doi.org/10.1186/2051-1426-2-s3-p1 Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
https://doi.org/10.1097/md.0000000000026673 The safety and efficacy of chemotherapy combined with immunotherapy for pancreatic cancer
https://doi.org/10.14219/jada.archive.1978.0130 Human pulpal response to citric acid cavity cleanser
https://doi.org/10.4049/jimmunol.176.2.1036 T-bet Down-Modulation in Tolerized Th1 Effector CD4 Cells Confers a TCR-Distal Signaling Defect That Selectively Impairs IFN-γ Expression
https://doi.org/10.4161/onci.22308 Advancing the field of cancer immunotherapy
https://doi.org/10.14419/ijaes.v3i1.3867 Accruals and the prediction of future operating cash-flows: evidence from Tunisian companies
https://doi.org/10.1038/sj.leu.2404453 Enhanced CD28 signaling may be a common mechanism underlying resistance to regulation
https://doi.org/10.1097/01.cji.0000211343.73588.59 Activated Human B Cells can Secrete Granzyme B and Gain Cytotoxic Potential in Response to Interleukin 21
https://doi.org/10.1097/jp9.0000000000000057 Gut Microbiome: The Third Musketeer in the Cancer-Immune System Cross-Talk
https://doi.org/10.1200/jco.2019.37.15_suppl.e18224 Effects of online education on the identification and management of immune-related adverse events over time.
https://doi.org/10.1016/j.jtct.2022.05.034 Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation
https://doi.org/10.1200/jco.2019.37.15_suppl.e18249 Online education about lung cancer immunotherapy: Outcomes over time.
https://doi.org/10.1136/jitc-2023-008508 Toward standardization in bladder cancer clinical trials: Guidance from the SITC-IBCG expert panel
https://doi.org/10.1006/prep.2001.1462 SwellGel: An Affinity Chromatography Technology for High-Capacity and High-Throughput Purification of Recombinant-Tagged Proteins
https://doi.org/10.1080/15265161003708425 Reflections on the Golubchuk Case
https://doi.org/10.1016/j.jim.2014.05.003 The role of the reporting framework MIATA within current efforts to advance immune monitoring
https://doi.org/10.1186/1479-5876-9-60 Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer
https://doi.org/10.1186/2051-1426-2-s3-p154 Detection and functional assessment of regulatory T cells in clinical samples
https://doi.org/10.1080/00913847.1992.11947428 forum
https://doi.org/10.1186/2051-1426-2-s3-p67 T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
https://doi.org/10.1186/2051-1426-2-15 Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
https://doi.org/10.1186/2051-1426-3-s2-p135 Identification of continued challenges and opportunities in oncologists' comprehension of immuno-oncology
https://doi.org/10.1089/cren.2015.29016.maa Polyisobutylene Urolithiasis Due to Ileal Conduit Urostomy Appliance: An Index Case
https://doi.org/10.4049/jimmunol.194.supp.63.8 Targeting regulatory T cells in chronic inflammatory disease. (MPF2P.749)
https://doi.org/10.1002/cam4.6582 Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy
https://doi.org/10.1186/2051-1426-2-s3-p90 Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
https://doi.org/10.1016/s0022-5223(19)43347-3 Chemotherapy and lung cancer-present status
https://doi.org/10.1186/2051-1426-1-s1-p250 Expression of cancer testis antigens and its correlation with clinicopathological parameters in hepatocellular carcinoma
https://doi.org/10.1586/era.10.229 Pioneering the trail of cancer immunotherapy
https://doi.org/10.1186/2051-1426-1-s1-p246 Expression of cancer-testis antigen in patients with non-small cell lung cancer and its clinical relevance
https://doi.org/10.1097/00002371-200305000-00001 SBT Becomes the iSBTc: The State of the Society - 2003
https://doi.org/10.1200/jco.2015.33.15_suppl.e20041 Identifying the baseline: Oncologists’ understanding of cancer immunotherapy in metastatic melanoma.
https://doi.org/10.1200/jco.2018.36.6_suppl.651 Integrating a paradigm shift into treatment of renal cell cancer: Effect of online CME on oncologists' knowledge and competence.
https://doi.org/10.2217/ebo.11.260 Melanoma & biomarkers of immunoresponsiveness
https://doi.org/10.1200/jco.2016.34.15_suppl.e20592 Use of cancer immunotherapies in advanced NSCLC: Persistant challenges among oncologists.
https://doi.org/10.1200/jco.2019.37.15_suppl.10533 Online education about immunotherapy for melanoma: Outcomes over time.
https://doi.org/10.31176/apertura.2019.14.3.5 A digitális bölcsészet sötét oldala: Tudósítás két nemrégiben megrendezett MLA konferenciáról
https://doi.org/10.1186/2051-1426-2-s3-p19 Genetic engineering of T cells for increased homing to the tumor site
https://doi.org/10.1136/jitc-2022-005207 Celebrating a decade of the Journal for ImmunoTherapy of Cancer
https://doi.org/10.3389/fnut.2025.1606634 Editorial: Ketogenic metabolic therapy as a treatment for mental health disorders
https://doi.org/10.1158/1078-0432.ccr-25-0327 Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor–Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study
https://doi.org/10.1016/j.esmorw.2025.100616 420P International consensus for training an external and synthetic (EASY) control arm using AI- [generation of patient-bots “botients” to replace human beings in controls arms in oncology trials]
https://doi.org/10.1182/blood-2025-4234 Control of gvhd by probiotics with a single strain of muribaculaceae bacterium through secretory proteins
https://doi.org/10.1080/10428194.2025.2595221 Serological pseudoprogression of multiple myeloma after treatment with teclistamab
https://doi.org/10.1182/blood-2025-2401 Optimizing the manufacturing and delivery of LV20.19 CAR T cells for relapsed, refractory DLBCL and FL